Concepedia

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Benjamin M. Scirica, Eugene Braunwald, Itamar Raz, Matthew A. Cavender, David A. Morrow, Petr Jarolı́m, Jacob A. Udell, Ofri Mosenzon, KyungAh Im, Amarachi Umez-Eronini,

Circulation · 2014 · 718 citations · 30 references

Abstract

http://www.clinicaltrials.gov. Unique identifier: NCT01107886.

References

30

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

The Lancet · 1998 · 19.9K citations

Metabolic Syndrome, Diabetes Management, Insulin Management +9

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

R. C. Turner, Charles Fox, Matthews et al. · The Lancet · 1998 · 8.4K citations

Metabolic Syndrome, Diabetes Management, Diabetes Epidemiology +10

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

The Lancet · 1998 · 8.2K citations

Obesity, Metabolic Syndrome, Diabetes Management +10

Effects of Intensive Glucose Lowering in Type 2 Diabetes

New England Journal of Medicine · 2008 · 7.8K citations · Full text

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine · 2008 · 7.3K citations · Full text